Premium Reports
Medication Inventory Management 2019

Medication Inventory Management 2019
How Close Is Your Vendor to Enabling True Enterprise MIM?

Authored by: Jackson Tate & Paul Warburton August 13, 2019 | Read Time: 3  minutes

Current Time Inside Cache Tag Helper: 4/20/2021 9:49:14 AM and Model.reportId = 1466

Enterprise medication inventory management (MIM) can create substantial efficiency gains and financial savings, but the reality today is that no pharmacy or EMR vendor delivers the full visibility hospitals need. Even those vendors furthest down the path lag behind the inventory capabilities found in other industries, such as retail and manufacturing. To highlight which vendors have made progress and where gaps still remain, this report compares the reality of each vendor’s MIM offering with the full spectrum of capabilities required for true enterprise MIM. Additional findings are also highlighted in two areas that impact MIM—automated dispensing cabinets and medication kit/tray management solutions.

Healthcare Providers,
Want to see full details?

Not a Provider, contact us for pricing details.

Current Time Inside Cache Tag Helper: 4/20/2021 9:49:14 AM and Model.reportId = 1466

Key Findings

  1. Omnicell Furthest on the Road to Enterprise MIM; Customers Often Unclear on Future Vision
  2. Customers Still Waiting for BD HealthSight to Become Generally Available
  3. Gaps in Integration and Visibility Tied to Low Purchase Energy for ARxIUM, Swisslog, Epic, & Cerner
  4. Hardware Defects in New Omnicell XT Lead to Downtime and Manual Inventory Counting
  5. Kit Check and IntelliGuard Offer Accurate Visibility and Expiration Tracking; Inmar First to Provide Non-RFID Option
 Download Report Brief  Download Full Report

This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2021 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.